The following information is provided by Tissue Genesis:
Honolulu's own Tissue Genesis, Inc. was recently awarded a two-year, $2.1 million contract with the NASA Ames Research Center (ARC) to develop the next generation cell culture system for conducting long-duration biological research on board the International Space Station (ISS). Over the next two years, Tissue Genesis will develop a dedicated bioculture incubator system capable of supporting a diversity of space flight experiments. Delivery to the ISS via SpaceX Dragon spacecraft is tentatively slated for February 2014.
Tissue Genesis most recently joined with NASA and the DoD for STS-135, the final shuttle mission of NASA's Space Shuttle Program.